Herbal Composition for BPH Symptom Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for prostate disorders such as benign prostatic hyperplasia (BPH), prostatitis, and prostatic intraepithelial neoplasia often have significant side effects and do not adequately address urinary incontinence, overactive bladder, and nocturia, with limited timeframes for symptom improvement.
Innovation Solution
A herbal composition comprising Crateva nurvala, Equisetum arvense, Lindera aggregata, and Serenoa repens, formulated as oral dosage units in various delivery systems, including tablets, capsules, and controlled-release vehicles, to provide a comprehensive treatment for prostate and bladder symptoms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional pharmaceutical treatments (alpha-blockers and 5-alpha-reductase inhibitors) are used to treat BPH, then prostate enlargement and urinary obstruction are reduced, but significant side effects occur including sexual dysfunction, hypotension, and dizziness
Solution Approach 1:
The patent replaces long-term pharmaceutical treatments with a natural herbal composition that can be discontinued without severe withdrawal effects. The herbal formulation uses naturally occurring compounds from plants like saw palmetto, pygeum africanum, and stinging nettle that work with the body's natural systems rather than suppressing them, allowing for treatment cessation without the persistent side effects of synthetic drugs.
Solution Approach 2:
The patent employs a composite herbal formulation combining multiple plant extracts (saw palmetto, pygeum africanum, stinging nettle, beta-sitosterol, lycopene, zinc) that work synergistically to treat BPH. This composite approach addresses multiple pathways involved in prostate enlargement simultaneously, providing comprehensive treatment while minimizing side effects through the use of naturally occurring compounds.
2Ease of operation
If surgery is performed to relieve severe BPH symptoms, then urinary obstruction is immediately relieved, but complications including incontinence, impotence, and retrograde ejaculation occur
Solution Approach 1:
The patent enables preliminary treatment of BPH symptoms through herbal supplementation before surgical intervention becomes necessary. By addressing prostate enlargement and urinary obstruction through natural compounds, patients may avoid surgery altogether or require less aggressive surgical procedures, thereby preventing surgical complications before they occur.
Solution Approach 2:
The patent converts the gradual, progressive nature of BPH into a manageable condition through continuous herbal treatment. Rather than allowing the condition to progress to a point requiring surgery, the herbal formulation continuously manages prostate size and urinary flow, transforming a potentially harmful surgical necessity into a manageable chronic condition.
3Reliability
If current BPH treatments focus primarily on prostate enlargement, then prostate size is reduced, but associated symptoms like urinary incontinence, overactive bladder, and nocturia are not adequately addressed
Solution Approach 1:
The patent creates a multi-functional herbal formulation that simultaneously addresses prostate enlargement and associated bladder symptoms. The combination of ingredients targets multiple systems: saw palmetto and pygeum africanum reduce prostate size, while beta-sitosterol, lycopene, and zinc support bladder function, reduce inflammation, and improve urinary flow. This universal approach treats the entire urogenital system rather than isolating the prostate.
Solution Approach 2:
The patent segments the treatment approach into distinct functional components: ingredients that reduce prostate size (saw palmetto, pygeum), ingredients that improve urinary flow (beta-sitosterol, stinging nettle), ingredients that reduce inflammation (licorice root, green tea), and ingredients that support bladder function (zinc, lycopene). Each component addresses a specific aspect of BPH, and their combination provides comprehensive coverage of all symptoms.
Data Source
AI summary
Provided in one embodiment is an herbal composition for the prevention or treatment of disorders of the prostate, for example, benign prostatic hyperplasia (BPH), prostatitis, and prostatic intraepithelial neoplasia, and for overactive bladder (OAB), urinary incontinence (UI), nocturia, poor urinary stream, and straining to urinate associated with these prostate disorders. Specifically one embodiment provides compositions that contain Crateva nurvala, Equisetum arvense, Lindera aggregata, and Serenoa repens, and methods of use thereof.


